0
0
10/26/25 at 9:28am
Organization
Medical News Today
Author
Corrie Pelc
33 words
0
Comments
Phase 3 clinical trial results of an investigational drug has shown benefits in treating people with APOE4/4 with early Alzheimer's disease.
You are the first to view
https://www.medicalnewstoday.com/articles/first-alzheimers-oral-pill-genetic-risk-benefit-phase-3-trial
Create an account
or login to join the discussion